Détail du document
Identifiant
doi:10.1186/s13020-023-00822-9...
Auteur
Jiang, Rui-yuan Fang, Zi-ru Zhang, Huan-ping Xu, Jun-yao Zhu, Jia-yu Chen, Ke-yu Wang, Wei Jiang, Xiao Wang, Xiao-jiaLangue
enEditeur
BioMed Central
Catégorie
Medicine & Public Health
Année
2023
Date de référencement
27/09/2023
Mots clés
ginsenoside breast cancer hallmarks of cancer apoptosis epithelial-mesenchymal transition cell growth therapeutic cancer hallmarks breastRésumé
In 2021, breast cancer accounted for a substantial proportion of cancer cases and represented the second leading cause of cancer deaths among women worldwide.
Although tumor cells originate from normal cells in the human body, they possess distinct biological characteristics resulting from changes in gene structure and function of cancer cells in contrast with normal cells.
These distinguishing features, known as hallmarks of cancer cells, differ from those of normal cells.
The hallmarks primarily include high metabolic activity, mitochondrial dysfunction, and resistance to cell death.
Current evidence suggests that the fundamental hallmarks of tumor cells affect the tissue structure, function, and metabolism of tumor cells and their internal and external environment.
Therefore, these fundamental hallmarks of tumor cells enable tumor cells to proliferate, invade and avoid apoptosis.
Modifying these hallmarks of tumor cells represents a new and potentially promising approach to tumor treatment.
The key to breast cancer treatment lies in identifying the optimal therapeutic agent with minimal toxicity to normal cells, considering the specific types of tumor cells in patients.
Some herbal medicines contain active ingredients which can precisely achieve this purpose.
In this review, we introduce Ginsenoside's mechanism and research significance in achieving the therapeutic effect of breast cancer by changing the functional hallmarks of tumor cells, providing a new perspective for the potential application of Ginsenoside as a therapeutic drug for breast cancer.
Jiang, Rui-yuan,Fang, Zi-ru,Zhang, Huan-ping,Xu, Jun-yao,Zhu, Jia-yu,Chen, Ke-yu,Wang, Wei,Jiang, Xiao,Wang, Xiao-jia, 2023, Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer, BioMed Central
Configurable Safety Tuning of Language Models with Synthetic Preference Data
data preference cst dpo configurable language safety
Affective flexibility as a developmental building block of cognitive reappraisal: An fMRI study
cognitive success affective flexibility
